Advertisement
The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
Subscribe to Pharmaceutical Processing
View Sample

FREE Daily Email Newsletter

Genentech Alzheimer's Drug Misses Goals in Studies

July 16, 2014 1:45 pm | by MARILYNN MARCHIONE, AP Chief Medical Writer | News | Comments

An experimental drug from Genentech failed to slow mental decline in mid-stage studies on more than 500 people with mild to moderate Alzheimer's disease, but showed some promise in the least-impaired participants who received a higher dose.  

TOPICS:

Ceiling Mounted Air Filtration Units

July 16, 2014 12:13 pm | by Nikita Ernst, Associate Editor | Air Science Usa | Product Releases | Comments

These ceiling mounted filtration units are designed to protect laboratory personnel and the environment in areas where hazardous substances are handled.

FDA Issues Draft Information Sheet Guidance on Informed Consent

July 16, 2014 11:42 am | News | Comments

This draft guidance is intended to assist IRBs, clinical investigators, and sponsors involved in clinical investigations of FDA-regulated products in carrying out their responsibilities related to informed consent.      

TOPICS:
Advertisement

Aptuit Names Executive VP, Business Development & Marketing; Enhances Sterile Drug Product Capabilities

July 16, 2014 11:33 am | News | Comments

Aptuit LLC has appointed Paul D. Overton, Ph.D., as Executive Vice President, Business Development and Marketing, making him responsible for all of Aptuit’s sales and marketing activities.           

TOPICS:

Strides Arcolab Makes Investments in Oncobiologics

July 16, 2014 11:28 am | News | Comments

The investment is part of Strides' strategy to fund promising biopharma companies with high quality scientific management and proprietary approaches to developments that confer significant time and cost advantages.      

TOPICS:

Pfizer Survey Reveals 87% of Americans have a Fear of Getting Old (FOGO)

July 16, 2014 11:15 am | News | Comments

Life expectancy continues to climb — up to more than 81 years for women and 76 years for men – but many of us have concerns around aging. Pfizer is challenging Americans to address their #FOGO – Fear of Getting Old – as the next phase of Get Old, an initiative by Pfizer around aging, encouraging honest conversations and celebrating getting “old” at whatever stage of life you are.

TOPICS:

Abbott Second Quarter Profit Falls on Higher Taxes, Revenue Up

July 16, 2014 9:37 am | News | Comments

Abbott Laboratories said that its second-quarter profit declined 2.1 percent, hampered by higher taxes. Adjusted profit and revenue topped Wall Street expectations, however, and the company boosted its full-year earnings forecast.    

TOPICS:

Pfizer to Acquire InnoPharma

July 16, 2014 9:34 am | News | Comments

Pfizer and InnoPharma, a privately held pharmaceutical development company, today announced that they have entered into an agreement under which Pfizer will acquire InnoPharma. Under the terms of the agreement, Pfizer will acquire InnoPharma for an upfront cash payment of $225 million, with up to $135 million of contingent milestone payments.

TOPICS:
Advertisement

Opinion: Big Government Can Kill You

July 16, 2014 9:06 am | Videos | Comments

Committee to Reduce Infection Deaths Chairman Betsy McCaughey on the CDC’s admission that its scientists mishandled anthrax and deadly flu strains.                  

TOPICS:

GSK and Theravance Initiate Phase III Program for COPD Treatment

July 16, 2014 8:53 am | News | Comments

GlaxoSmithKline and Theravance today announced the start of a global phase III study, known as IMPACT, to evaluate the efficacy and safety of the 'closed' triple combination of FF/UMEC/VI in patients with chronic obstructive pulmonary disease (COPD).

TOPICS:

Study: US Alzheimer's Rate Seems to Be Dropping

July 16, 2014 8:47 am | by MARILYNN MARCHIONE, AP Chief Medical Writer | News | Comments

The rate of Alzheimer's disease and other dementias is falling in the United States and some other rich countries — good news about an epidemic that is still growing simply because more people are living to an old age, new studies show.

TOPICS:

Number of People with HIV Unchanged Since 2012

July 16, 2014 8:45 am | by MARIA CHENG, AP Medical Writer | News | Comments

The number of people living with HIV worldwide has remained virtually unchanged in the past two years and AIDS-related deaths are at their lowest since peaking almost a decade ago, according to a report from the United Nations AIDS agency released Wednesday.

TOPICS:

West Dedicates Pharmaceutical Manufacturing Plant in India

July 16, 2014 8:41 am | News | Comments

In June 2012, West signed a 99-year lease on 72,800 square meters (approximately 783,600 square feet) of land in Sri City. Sri City offers the advantages of a metropolitan location and was selected primarily on the suitability of land, availability of utilities, labor suitability, logistics and quality of life.

TOPICS:

FDA Approves Purdue Pharma’s 7.5 mcg/hour Dosage Strength of Butrans

July 16, 2014 8:31 am | News | Comments

Purdue Pharma announced that the FDA has approved a new 7.5 mcg/hour dosage strength of Butrans (buprenorphine) Transdermal System CIII. Five strengths of Butrans will now be available: 5 mcg/hour, 7.5 mcg/hour, 10 mcg/hour, 15 mcg/hour and 20 mcg/hour.

TOPICS:

The State Of Track & Trace Technology: Is The Industry Ready?

July 15, 2014 1:03 pm | by Kelly Ng, Product Manager, Healthcare, Epson America | Articles | Comments

As serialization becomes an ever more important part of the pharmaceutical industry and the FDA's track & trace deadlines loom in the distance, we sat down with Kelly Ng, the Healthcare division's Product Manage at Epson, to talk about the state of track and trace/serialization technology, whether the industry is ready for the new requirements and how companies can make sure that they will make the upcoming deadlines. 

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading